Stage IA Breast Cancer Withdrawn Phase 4 Trials for Letrozole (DB01006)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03238703Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerTreatment